Lifeward receives payment from Medicare for ReWalk 7 Personal Exoskeleton

Lifeward (LFWD) announced that it received its first payment from a commercial Medicare Advantage Plan for a ReWalk 7 Personal Exoskeleton. “As we continue to submit claims to broaden access to exoskeletons for individuals living with spinal cord injury, we are seeing momentum, both in the number of payers participating and also in how quickly claims for the ReWalk 7 Personal Exoskeleton are being approved” said Mark Grant, CEO of Lifeward. “We’re especially pleased to begin including Medicare Advantage Plans among our reimbursing payers, helping ensure consistent access and equality of care across the full range of Medicare options.”